TY - JOUR
T1 - Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies
AU - Davis, Darryl R.
AU - Kizana, Eddy
AU - Terrovitis, John
AU - Barth, Andreas S.
AU - Zhang, Yiqiang
AU - Smith, Rachel Ruckdeschel
AU - Miake, Junichiro
AU - Marbán, Eduardo
N1 - Funding Information:
This study was supported by the NIH ( U54 HL081028 and R01 HL083109 ) and Dr Davis is funded by the Canadian Institutes of Health Research (Clinician Scientist Award). In terms of competing interests, Dr Eduardo Marbán holds equity in a private company (Capricor Inc.) that licenses techniques used to manufacture cardiac stem cells. Dr Rachel Ruckdeschel Smith is presently employed by Capricor Inc. Capricor provided no support for this study. The remaining authors have nothing to disclose.
PY - 2010/8
Y1 - 2010/8
N2 - The adult heart contains reservoirs of progenitor cells that express embryonic and stem cell-related antigens. While these antigenically-purified cells are promising candidates for autologous cell therapy, clinical application is hampered by their limited abundance and tedious isolation methods. Methods that involve an intermediate cardiosphere-forming step have proven successful and are being tested clinically, but it is unclear whether the cardiosphere step is necessary. Accordingly, we investigated the molecular profile and functional benefit of cells that spontaneously emigrate from cardiac tissue in primary culture. Adult Wistar-Kyoto rat hearts were minced, digested and cultured as separate anatomical regions. Loosely-adherent cells that surround the plated tissue were harvested weekly for a total of five harvests. Genetic lineage tracing demonstrated that a small proportion of the direct outgrowth from cardiac samples originates from myocardial cells. This outgrowth contains sub-populations of cells expressing embryonic (SSEA-1) and stem cell-related antigens (c-Kit, abcg2) that varied with time in culture but not with the cardiac chamber of origin. This direct outgrowth, and its expanded progeny, underwent marked in vitro angiogenic/cardiogenic differentiation and cytokine secretion (IGF-1, VGEF). In vivo effects included long-term functional benefits as gauged by MRI following cell injection in a rat model of myocardial infarction. Outgrowth cells afforded equivalent functional benefits to cardiosphere-derived cells, which require more processing steps to manufacture. These results provide the basis for a simplified and efficient process to generate autologous cardiac progenitor cells (and mesenchymal supporting cells) to augment clinically-relevant approaches for myocardial repair.
AB - The adult heart contains reservoirs of progenitor cells that express embryonic and stem cell-related antigens. While these antigenically-purified cells are promising candidates for autologous cell therapy, clinical application is hampered by their limited abundance and tedious isolation methods. Methods that involve an intermediate cardiosphere-forming step have proven successful and are being tested clinically, but it is unclear whether the cardiosphere step is necessary. Accordingly, we investigated the molecular profile and functional benefit of cells that spontaneously emigrate from cardiac tissue in primary culture. Adult Wistar-Kyoto rat hearts were minced, digested and cultured as separate anatomical regions. Loosely-adherent cells that surround the plated tissue were harvested weekly for a total of five harvests. Genetic lineage tracing demonstrated that a small proportion of the direct outgrowth from cardiac samples originates from myocardial cells. This outgrowth contains sub-populations of cells expressing embryonic (SSEA-1) and stem cell-related antigens (c-Kit, abcg2) that varied with time in culture but not with the cardiac chamber of origin. This direct outgrowth, and its expanded progeny, underwent marked in vitro angiogenic/cardiogenic differentiation and cytokine secretion (IGF-1, VGEF). In vivo effects included long-term functional benefits as gauged by MRI following cell injection in a rat model of myocardial infarction. Outgrowth cells afforded equivalent functional benefits to cardiosphere-derived cells, which require more processing steps to manufacture. These results provide the basis for a simplified and efficient process to generate autologous cardiac progenitor cells (and mesenchymal supporting cells) to augment clinically-relevant approaches for myocardial repair.
KW - Angiogenesis
KW - Cardiac regeneration
KW - Cell therapy
KW - Myocardial infarction
KW - Ventricular remodelling
UR - http://www.scopus.com/inward/record.url?scp=77953726551&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953726551&partnerID=8YFLogxK
U2 - 10.1016/j.yjmcc.2010.02.019
DO - 10.1016/j.yjmcc.2010.02.019
M3 - Article
C2 - 20211627
AN - SCOPUS:77953726551
SN - 0022-2828
VL - 49
SP - 312
EP - 321
JO - Journal of Molecular and Cellular Cardiology
JF - Journal of Molecular and Cellular Cardiology
IS - 2
ER -